Today In Focus

US obesity rates dip amid rise of weight loss drugs like Ozempic

US obesity rates dip amid rise of weight loss drugs like Ozempic


IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    US obesity rates decline for the first time in more than a decade

    00:23

  • UP NEXT

    Dodgers’ World Series walk-off grand slam baseball sells for $1.5M

    00:28

  • You can own this historic Massachusetts lighthouse for $1.2M

    03:56

  • Sheinelle Jones on the special message Biden shared with her son

    01:43

  • 4-year-old girl steals mic at Christmas concert for hilarious address

    01:03

  • Crown of Thorns returns to Notre Dame Cathedral in Paris

    00:34

  • Christmas-related tourism boom has locals calling for crowd control

    02:30

  • Push to end daylight saving time gets help from the President-elect

    03:17

  • Mystery drones: Get a close up look at an example of a large drone

    04:54

  • Rare tornado rips through Scotts Valley, California

    00:19

  • Incoming Los Angeles DA voices skepticism about Menendez case

    02:19

  • Israel strikes targets in Syria, as control hangs in balance

    02:25

  • Pete Hegseth to release accuser from non-disclosure agreement

    02:26

  • New details in Luigi Mangione’s arrest and life behind bars

    01:55

  • Feds step in as number of states reporting drone sightings grows

    03:18

  • George Kresge, The Amazing Kreskin, dies at 89

    02:15

  • Residents remain frustrated over mysterious drones in 5 states

    05:08

  • Nancy Pelosi undergoes hip replacement in Germany after fall

    00:22

  • Would Republican senators block a Trump cabinet pick?

    01:58

  • Trump attends Army-Navy game with embattled cabinet picks

    02:05

A new study published in the JAMA Health Forum found that obesity rates dropped from 46% in 2022 to 45.6% in 2023. The study suggests the drop might be linked to a rise in popularity of weight loss drugs.



Source

Share your love
Facebook
Twitter
Newsletter

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *